Gene Therapy Platform

• M&A / Deals

Latus Bio secures $97m in funding to boost gene therapy access

pharminent May 5, 2026

• Regulatory

Gene therapy’s evidence problem–lessons from recent FDA decisions

pharminent May 4, 2026

• M&A / Deals

LEO Pharma to acquire gene therapy company Replay

pharminent May 1, 2026

• Regulatory

Ray Therapeutics receives EMA PRIME status for gene therapy

pharminent April 30, 2026

• M&A / Deals

Rocket to sell PRV for $180m to advance gene therapy pipeline

pharminent April 29, 2026

• Pipeline

Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases

pharminent April 27, 2026

• Gene Therapy

Gene therapy leaders aim to help more Baby KJs with novel regulatory models

pharminent April 27, 2026

• Policy / Pricing

Regeneron cuts White House pricing deal, offers new gene therapy for free

pharminent April 24, 2026

• Pipeline

Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine

pharminent April 21, 2026

• M&A / Deals

Eli Lilly doubles down on in vivo with $7bn Kelonia buyout

pharminent April 21, 2026

• M&A / Deals

Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout

pharminent April 20, 2026

• M&A / Deals

Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal

pharminent April 20, 2026

• Other

The innovators working to make in vivo cell therapy a reality

pharminent April 17, 2026

• Regulatory

FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development

pharminent April 14, 2026

• Other

219: An Interview With Dr. Natalie Truba on the Psychological Aspects of Gene Therapy

pharminent April 7, 2026